Virbac says HCA targets specific affected topical areas with negligible systemic absorption, to provide direct and rapid relief from inflammation and pruritus, delivering significant clinical improvement in atopic cases, both lesion and pruritus scores, after 14 days1.
Cortavance can be applied daily for up to 28 days and included within multimodal treatment plans for prolonged use to control atopy.
Cortavance is presented in a new ergonomic-shaped bottle allowing the user to accurately target the problem area at any angle, with its no-hand-contact spray applicators - 31ml and 76ml sizes.
For further information, contact your local Virbac Territory Manager.
Reference
The proceedings will begin at 10am with the formal adoption by RCVS Council of the Annual Report and Financial Statements for 2020, which will be published prior to the event.
The College will then answer any written questions that have been submitted about the Annual Report by veterinary surgeons and veterinary nurses.
If you have any questions about the Annual Report, you'll need to submit them to RCVS Events Manager Deborah Rowlanes on d.rowlanes@rcvs.org.uk no later than Friday 2 July 2021.
RCVS President Mandisa Greene will then formally welcome the newly-elected RCVS Council members – Louise Allum, Danny Chambers, Tshidi Gardiner and Colin Whiting – onto Council for their four-year terms, and newly-elected VN Council members Susan Howarth and Donna Lewis for their three-year terms, as well as saying farewell to retiring members of both Councils.
After a short break, the AGM will reconvene at 11am to approve Kate Richards (pictured right) as President for 2021-22, Melissa Donald as Junior Vice-President, Mandisa as Senior Vice-President, and Niall Connell as Treasurer.
There will then be addresses from Matthew Rendle as Chair of Veterinary Nurses Council, and from Mandisa as the outgoing RCVS President for 2020-21, followed by the formal investiture of the new RCVS Officer Team.
There will then be closing remarks from Kate Richards as the newly invested RCVS President.
If you'd like to attend the AGM, you'll need to register here: www.rcvs.org.uk/agm21-registration.
Credelio Plus is a palatable, chewy, monthly tablet which contains milbemycin oxime for the control of the gastrointestinal nematodes: hookworm (L4, immature adult (L5) and adult Ancylostoma caninum), roundworms (L4, immature adult (L5) and adult Toxocara canis and adult Toxascaris leonina) and whipworm (adult Trichuris vulpis). Also for the prevention of angiostrongylosis by reduction of the level of infection with immature adult (L5) and adult stages of Angiostrongylus vasorum (lungworm) with monthly administration. Also for the prevention of heartworm disease (Dirofilaria immitis).
Credelio Plus also contains lotilaner for the immediate and persistent treatment of ticks (Dermacentor reticulatus, Ixodes ricinus, Rhipicephalus sanguineus and I. hexagonus) and flea (Ctenocephalides felis and C. canis) infestations in dogs.
Credelio Plus is licensed for puppies as young as 8 weeks and weighing 1.4 kg or more.
Tina Hunt, General Manager of Elanco UK/Ireland said: "The launch of Credelio Plus represents another exciting evolutionary leap for Elanco’s parasiticide portfolio.”
Cat Henstridge MRCVS, otherwise known as 'Cat the Vet' said: "As a companion animal vet, one of the common challenges I see from pet owners is the need to remember and administer multiple treatments to cover a variety of parasites.
"So a simple, easy-to-remember treatment will be welcomed by my clients who need a combination solution to protect their dogs from ticks, fleas and worms.”
To mark the launch of Credelio Plus, Elanco is inviting vets and nurses to register for an online event at which the astronaut Major Tim Peake will talk about the lessons he’s learnt about leadership and teamwork, performing in high-pressured environments and the future of medicine and science. He'll be followed by Cat Henstridge, who will give a presentation about the power of wider veterinary teams working ‘better together’ to support each other, and how practices can start to reconnect with their clients following lockdown.
Lepha McCartan, BVetMed MRCVS, Veterinary Technical Consultant, Elanco Animal Health, will also speak about Elanco’s ongoing work within the parasite space. There will also be a live Q&A where attendees can put questions to the panel.
To sign up for the launch event, visit https://www.myelanco.co.uk/brand/credelio-plus-launch-registration
Richard was elected to RCVS Council in 2020, having previously served as an elected member from 2008 to 2016.
Over the years, he has also been a significant and valued contributor to VetSurgeon.org, and his insight will be missed.
RCVS President Mandisa Greene said: “We thank Richard for his service to the RCVS over the past year and in his previous terms. We particularly thank him for his contribution to a number of committees he has served on during both his periods on Council including the Disciplinary, Finance & Resources and Preliminary Investigation Committees. We wish him all the best for the future.”
Professor Stephen May has now taken up the remainder of Richard’s term on Council, to July 2024, as he received the next largest amount of votes in the 2020 RCVS Council election.
Mr Eccles had first appeared before the Disciplinary Committee in November 2018 where he admitted a number of clinical failings regarding his diagnosis of a cat, the keeping of accurate and detailed clinical records, giving the animal appropriate treatment, surgery and care, and failing to provide the cat’s owners with adequate information on the cat’s care upon discharge.
After Mr Eccles admitted the two charges against him, and the Committee found him guilty of serious professional misconduct, the Committee then postponed its decision on sanction on the condition that Mr Eccles agreed to abide by a set of undertakings in the interim. They included: the preparation of a personal development plan, the enrolment of his practice in the RCVS Practice Standards Scheme, the appointment of a veterinary mentor, the completion of additional training and CPD, and his agreement to pay any costs of complying with the undertakings, including the appointment of and work undertaken by the appointed mentor.
At the resumed hearing last week, the Committee received evidence from Mr Eccles confirming that he had complied with all the original undertakings agreed to in 2018. It also considered some further undertakings that Mr Eccles had agreed to in October 2020 when his reconvened hearing was postponed due to the coronavirus pandemic. They included: confirming his compliance with the personal development plan he had drawn up in 2019, his practice achieving the Core Standards accreditation level within the Practice Standards Scheme, continuing to meet with his veterinary mentor, and undertaking additional CPD – all of which were found to be completed.
The Committee also heard evidence from both the veterinary mentor and Mr Eccles himself. In his evidence, Mr Eccles apologised to the owners of the cat for the care he had provided, admitting that he had let them and himself down by not having sufficient knowledge to recognise the cat’s needs and to provide him with a sufficient level of care. He also confirmed he was continuing to make improvements to his practice and that he had enjoyed the process of being mentored.
Dr Martin Whiting, chairing the Committee and speaking on its behalf, said: “In November 2018, Mr Eccles practice had fallen significantly short of an acceptable and adequate standard. He was a sole practitioner who had drifted away from professional standards.”
“The Committee today considers that Mr Eccles has met the undertakings which he accepted in November 2018 and again in October 2020 when the resumed hearing was adjourned owing to Covid-19. It accepts the College’s analysis as to how those standards have been met. It notes that Mr Eccles’ practice has achieved accreditation in Core Standards under the Practice Standard Scheme, something which is voluntary in ordinary practice. That is an exacting scheme. He has engaged with his mentor and had indicated that he will continue to do so as the need arises in order to maintain his development.”
Dr Whiting added: “The Committee also recognises that this was a single incident in a long career. It accepts that he has shown insight into his shortcomings. He understands what went wrong and why. The Committee was impressed with Mr Eccles’ statement of apology in his oral evidence today.”
“The Committee found the language which he used in answering its questions, as to the effect compliance with the undertakings has had upon him professionally, reassuring. He said he had been rejuvenated and stimulated; he had renewed enthusiasm for the profession. The Committee commends him for exceeding the minimum requirement of the undertakings, despite the stressful context of the Covid-19 pandemic.”
In considering its sanction for the original admitted charges from November 2018, the Committee considered that a reprimand and warning as to future conduct was the most appropriate and proportionate sanction.
The full findings for the case can be found at: www.rcvs.org.uk/disciplinary
The meeting, which is sponsored by Swann Morton, is the first in a series called ‘Let’s Talk About …’, where the idea is to get a small, representative group of eight general practitioners from around the country to come and put questions about a variety of different subjects to experts in their field, with the answers then being shared on YouTube for the benefit of colleagues not just in this country but around the world.
To apply to be one of the eight ‘questioners’ in ‘Let’s Talk About Small Animal Surgery', please email editor@vetsurgeon.org with your name, county and a question.
If you'd like to just watch the event, you can register here now.
Note that there may (or may not) be an opportunity for spectators to ask questions on the night. So if you want a VIP seat at the table, email your question as soon as possible.
For more information about Swann Morton, and its diverse range of Sheffield-made products incorporating the latest sharps safety solutions to protect the welfare of your in-house team, visit: www.swann-morton.com
UPDATE: THE RECORDING OF THIS MEETING IS NOW FREELY AVAILABLE FOR EVERYONE TO WATCH HERE, AND COUNTS TOWARDS YOUR CPD REQUIREMENT.
From now on, accredited General Practices will need to employ at least one Registered Veterinary Nurse (RVN), whilst at Veterinary Hospitals all patients should now have a nursing plan in place, and an RVN will need to be on duty at all times.
Other changes to the PSS requirements include:
The full list of changes to the Practice Standards Scheme, together with the new module and award documents, can be found at: www.rcvs.org.uk/PSSreview.
David Ashcroft leads the team of PSS Assessors responsible for undertaking practice visits and assessing if they meet the required standards. He said: “The changes will come into force later in the year, at the same time as we are planning to return to in-person assessments, and so timings will be subject to government guidance on coronavirus and the easing of lockdown restrictions.
“As the PSS returns to in-person assessments, practices will have the usual three-month period between booking the assessment and the assessment taking place with which to familiarise themselves with the changes and the modules documents relevant to their accreditation.
“If anyone has any questions about the changes then please make sure to contact the Practice Standards Team on pss@rcvs.org.uk and we will be happy to help in any way we can.”
The Congress, which is organised by Improve International, has separate streams for small animal medicine and small animal surgery and a dedicated veterinary nursing stream.
There will also be an exhibition of the latest innovations in veterinary products and services running alongside the lectures.
Helen Richmond, Head of Publishing at Improve said: “While technological innovation has made online congresses much more engaging and accessible over the last year, we felt the time was right to bring Vets North back in a face-to-face environment. Many of our previous delegates have already told us how much they are looking forward to being able to learn and enjoy some social time together again.
“As usual this year’s programme will include presentations and lectures from global experts, who will give advice and share knowledge that can be implemented in practice immediately. We would like to thank Elanco as our lead sponsor of this year’s Vets North and we also thank our other partners and sponsors for their support and loyalty during this difficult year.”
"Naturally, keeping delegates safe is our highest priority so we are working with the venue to ensure that the Government’s recommendations are implemented to the full and that Haydock Park is a COVID-secure venue.”
Early Bird tickets are available until the end of June.
For more information visit www.vetsnorth.com or call 01793 20805.
The company is also working with the UK charity to call for the creation of international standards in the training and deployment of sniffer dogs.
Earlier this week, Medical Detection Dogs announced the findings of its research on scenting COVID-19, confirming that dogs can play a major role in public safety through their ability to detect the virus’ odour.
Researchers will now move to trial the dogs at sites such as ports of entry and public spaces, where dogs can screen individuals rather than samples and contribute to the fight against the virus by detecting COVID-19 carriers.
Sniffer dog schemes are currently being piloted in countries including Finland, Russia, Italy and France, but there is currently no centralised best practice process for such programmes.
Medical Detection Dogs and Purina are calling for:
Medical Detection Dogs founder and CEO Dr Claire Guest said: “Sniffer dogs have the potential to make an important contribution to the fight against COVID-19 and future pandemics. Researchers around the world are urgently working to meet that need, but it is vital that we collaborate, share the knowledge we have gained on the incredible abilities of our dogs and formalise best practice in training and deployment.
"Along with Purina we want to call for international collaboration between organisations around the world on the implementation of disease detection and research. Our vision is to guarantee that dogs are well-treated and consistent in their performance, and support the reliable, safe creation of similar schemes in developing countries, where dogs could play a huge role in halting the spread of this disease and future pandemics.”
Jeff Hamilton, CEO at Nestlé Purina PetCare EMENA, said: “Purina and Medical Detection Dogs share a belief in the positive role and impact of dogs in society. These dogs could provide fast, effective and non-invasive diagnosis and help to create safer spaces for us all, but we should ensure that each of them is trained safely, humanely and able to effectively perform their important role in detecting COVID-19."
Procanicare contains three canine-specific strains of Lactobacillus bacteria, which the company says are proven to improve stool consistency, accelerate recovery following acute episodes of diarrhoea and improve well-being.1
The company also points to a number of studies which it says are evidence of the importance of supporting puppies' intestinal microbiomes.
'New puppy diarrhoea' is, it says, typically due to exposure to factors that are known to risk microbiome disturbance, such as diet change and going to a new home, at a time when the microbial population is at its more sensitive.2
Animalcare says other studies show that microbiome disturbances in early life can have a significant impact on health in adulthood.2,3
James Beaumont, Marketing Manager at Animalcare said: “We often hear from breeders, new puppy owners and vets that puppies which have had Procanicare seem brighter, have firmer stools and less flatulence. With the evidence mounting that the adult intestinal microbiome is shaped in early life and knowing the important and varied role that it has in wider health throughout life, we want to help vets proactively support the GI health of their youngest patients by providing Procanicare for them to trial, with no risk.”
References
SRUC, which is the biggest provider of veterinary nursing, livestock husbandry and animal care training in Scotland, says it will offer a core veterinary programme to address existing shortages in veterinary provision, in areas such as rural veterinary practice, food production, food safety and animal and public health.
The College is first establishing a working group to progress the plans for the school. The group will be chaired by Professor Sir Pete Downes, former Principal and Vice-Chancellor of the University of Dundee.
Sir Pete will be joined by Sheila Voas, Chief Veterinary Officer for Scotland, former NFUS President Nigel Miller, SRUC Board member Jane Craigie, and Dr Kate Richards, who is a non-executive director on the SAC Commercial Board and currently the junior vice president of the RCVS, in line to become President in July.
Professor Caroline Argo, currently Dean of SRUC’s North Faculty, will lead the project for SRUC.
A report from BiGGAR Economics has found that the vet school could add £26 million GVA and 242 jobs to Scotland by 2030.
Professor Wayne Powell, Principal and Chief Executive of SRUC, said: “We are an ambitious institution with a bold vision for the future. This is a ground-breaking model to expand access to educational opportunities and broaden the range of potential students who would not ordinarily be able to attend a vet school. It will also help solve existing skills shortages across Scotland.
“We see a key role of the new vet school in sustaining primary agriculture and hence food and drink productivity, with the welfare of both livestock and companion animals at its heart. The school will produce champions for best-in-class animal welfare in support of these industries, which will help improve productivity, effectiveness, and sustainability.”
“Building on the excellent new facilities we have already announced for Aberdeen and Inverness, there is a lot of work still to be done, but we are ready to seize the opportunity.”
Mr Chalkley faced three charges against him. The first was that he failed to identify some or all of the animals tested with Intradermal Comparative Tuberculin (ICT) tests at the farm.
The second charge was that Mr Chalkley had certified that he had carried out ICT tests on 279 animals at the farm and recorded the results on the accompanying paperwork but had, in fact, not adequately identified some or all of the 279 animals and had fabricated the skin thickness measurements recorded for some of them.
In addition, the charge alleged that Mr Chalkley’s conduct was dishonest, misleading and risked undermining government testing procedures designed to promote public health.
The third charge was that between June 2011 and September 2018, Mr Chalkley received payment of approximately £20,000 for ICT tests when, as a result of his conduct in relation to ICT tests at the farm, he was not entitled to such payment.
At the outset of the hearing Mr Chalkley admitted the first charge, that he had not adequately identified some of the animals.
On the third day of the hearing, during his evidence to the Committee, he admitted that his certification of the ICT testing was therefore misleading.
He denied the rest of the charges including that his conduct had been dishonest and that it had risked undermining government testing procedures designed to promote public health.
In considering the charges against Mr Chalkley, the Committee heard that discrepancies regarding the tests that were carried out on the farm in March 2018 were originally raised by the Animal and Plant Health Agency (APHA), on whose behalf Mr Chalkley carried out ICT testing in his capacity as an Official Veterinarian.
When Mr Chalkley gave evidence during the hearing, he explained that he had taken over TB testing for the farm in 2008 and that working conditions on the farm had been difficult throughout the whole period 2008 to 2018. He stated that due to the harsh weather conditions of early 2018, TB testing was difficult, and that the farmer needed to complete the test by March 2018 to avoid a financial penalty.
Mr Chalkley explained that one of the reasons for there being limited time available for him to carry out the test within the time required by the farmer was that he was due to provide veterinary cover at the Cheltenham races the following week and he was unable to find anyone else to cover the tests. Mr Chalkley also explained that during the tests on 5 and 8 March there had been limited farmhands available to assist in processing the cattle through the tests.
In the course of being asked questions by counsel for the RCVS, Mr Chalkley accepted that he had failed to identify some 45% of the animals he had injected on 5 March 2018 and had, in respect of each of the skin thickness measurements for those animals, randomly chosen a figure that he believed would be appropriate based on the breed, age and sex of the animal.
The APHA guidelines state that specific measurements should be made and recorded for each individual animal using callipers. Mr Chalkley said that he could not remember seeing the “pop-up” declaration which appeared when submitting the results to the APHA online and had never read it. He stated that he was not aware that he was making a declaration. However, he accepted that as an Official Veterinarian he was confirming that he had carried out the test properly. While he agreed that he knew that the test contained inaccuracies, he did not accept that he was being dishonest when he submitted the results.
Having considered all the evidence put forward by the RCVS and Mr Chalkley in his own defence, the Committee found that Mr Chalkley had acted dishonestly in deliberately choosing not to take the measurements on 5 March and had instead submitted fabricated alternatives, and so risked undermining public health by failing to carry out his duties as an OV.
The Committee also concluded that Mr Chalkley had been acting dishonestly, as he knew that he was submitting the test results as if they were the authentic outcome of a properly conducted test when in reality, they were no such thing.
The Committee did not accept Mr Chalkley’s evidence that he was unaware of the declaration which accompanied the submission of the test outcome. The Committee therefore found both the first and second charges proved.
In respect of the third charge the Committee found that this was not proven noting that the RCVS had not disproved Mr Chalkley’s explanation regarding his reasons for returning the £20,000 in fees he had received for carrying out TB testing at the farm from the APHA since 2011.
The Committee then considered whether the first two charges, both of which had been found proven, amounted to serious professional misconduct.
Ian Arundale, chairing the Committee and speaking on its behalf, said: “The Committee was prepared to accept that the respondent considered the risk arising from his actions as negligible. Nonetheless, in the Committee’s assessment a real risk existed due to the respondent’s actions and it was precisely the risk which the authorised testing procedure was designed to negate. The simple fact is the respondent could not be sure that each animal he assessed on 8 March 2018 had also been seen by him on 5 March 2018.
“However, the wider point with which the Committee was concerned related to the importance of any member of the profession or public being able to rely absolutely on the integrity of veterinary certification. Those parts of the Code and supporting guidance [concerning certification]… were unequivocal. It was very difficult to conceive of circumstances in which it could ever be justifiable to certify the outcome of a test which had not, in fact, been conducted in a way which was demonstrably valid and reliable. Such conduct was bound to be regarded as disgraceful by members of the profession and the general public.
“Honesty is the bedrock of appropriate certification and the Code and Guidance for the Disciplinary Committee is also unequivocal. Dishonesty in professional practice is always an extremely serious matter and the respondent’s responsibilities in the discharge of his functions as an Official Veterinarian were clear. On this occasion those responsibilities had been compromised.
“For these reasons, the Committee has come to the conclusion that the respondent’s conduct in relation to the facts found proved was disgraceful conduct in a professional respect.”
The Committee then went on to consider the sanction for Mr Chalkley.
The Committee heard oral evidence in mitigation, including from a former colleague who had worked with him in practice since 2006, as well as receiving a large number of written testimonials from various sources that attested to his honesty, integrity, willingness to help others, and charitable work in support of animal welfare.
Mr Chalkley’s counsel, in mitigation, highlighted his long and previously unblemished career, and characterised the conduct as an inexcusable but explicable error of judgement that was entirely isolated and out-of-character. Mr Chalkley’s counsel added that he had not done anything that he thought was seriously wrong, and there was no evidence that any harm had been done and that any risk to public health was not serious.
The Committee accepted that the conduct was isolated and out-of-character and that, furthermore, Mr Chalkley had made early and frank admissions to the APHA and that he had displayed a degree of insight, although the Committee was less confident that he truly understood the seriousness of the potential consequences of his dishonest conduct.
The Committee took into account the aggravating factors, including Mr Chalkley’s breach of trust of his position as an OV, the undermining of the integrity of veterinary certification, dishonesty and the potential public health impacts of his conduct.
Ian Arundale added: “The Committee considered that, having regard to the mitigating features which it had identified, a suspension order would be sufficient to send to the profession and the public a clear signal about the importance to be attached to accurate certification. The Committee considered that in the particular circumstances of this case, a period of three months suspension would be sufficient to achieve this objective.”
Melvyn was instrumental in shaping the success of the Trap, Neuter, Return, method of controlling feral cat populations. After meeting 60's supermodel Celia Hammond, scientist Dr. Jenny Remfry, and Peter Neville, a research biologist for UFAW, acted on their requests for better and more humane traps and engineered his first trap - the Eziset.
Melvyn went on to develop a dog grasper and a wide range of other handling products widely used in veterinary practice. He then developed the Mikki Muzzle, on the back of which he launched Mikki Pet Products, adding a range of grooming products.
In 1998, Melvyn sold Mikki to focus on his real passion – developing high welfare animal handling equipment and products sold via MDC Exports.
Ian MacFarlaine RVN said: "His impact on the veterinary world is only eclipsed by how much of a contribution he's made to animal charities globally, not just in inventing stuff, but then discounting it readily (through good and bad economic times) and then if that wasn't enough, giving thousands of pounds worth of it away at the ICAWC conference every year.
"If you were privileged enough to know him well, then you'll miss the kindness, the mischievous humour and the occasional bad taste joke. But I can guarantee that a little bit of Melvyn is there in each and every one of your practices in the form of one piece of equipment or other."
The three presentations, which are between 30 minutes and an hour in length, are aimed at vets but may also be of interest to veterinary nurses. They cover: ‘Topical therapy in canine atopic dermatitis’ and ‘Antimicrobial resistance’ presented by Dr Tim Nuttall and ‘Emotional considerations in dealing with dermatology cases’ by Dr Sarah Heath.
The presentations will be available for download from 7th June 2021, and viewers will be able to enter into a prize draw to win a £50 Love2Shop voucher and a free Cytology Manual.
To pre-register, visit: https://www.thewebinarvet.com/pages/ceva-dermatology-tea-time-top-ups-bite-size-cpd-sessions/
Zoetis says the new product is designed to stimulate both cell-mediated and antibody-based immunity, providing a broad immune response that mimics a natural infection.
The company says CircoMax Myco has demonstrated robust performance in field conditions, delivering improvements in average daily gain (ADG) and close-out weights versus negative controls, helping producers get more kilograms of pork to market.
CircoMax Myco comes in a ready to use single-dose combination with a duration of immunity (DOI) of 23 weeks against both PCV2 and M. hyopneumoniae.
Alvaro Aldaz, Director, Global Commercial Development, Swine, Zoetis, said: “The swine industry needs to adapt to evolving challenges and our research has consistently demonstrated that with its unique technology CircoMax Myco offers robust protection against PCV2 and M. hyopneumoniae.
"It also shows that this new product offers the best chance at protection against continuously evolving PCV2 genotypes – providing a broader umbrella for pig health and productivity.
"Analysis of new European PCV2 strains isolated in multiple countries confirm that CircoMax Myco offers broader coverage than competitor vaccines based on PCV2a only.”
The first meeting takes place on Thursday 27th May from 12.30pm to 1.30pm. It will look at how veterinary practices have had to work differently and adapt to the challenges posed by the coronavirus pandemic.
Chris Tufnell, RCVS Council Member and Innovation Lead (pictured right), will be chairing the session. He said: “In the past 15 months we have been in innovation overdrive, adapting at a unprecedented pace to transform how we work, serve our clients and patients, and continue to function as veterinary businesses in less-than-ideal circumstances.
"This event is an opportunity to take a step back, look at what has happened, how we have changed and consider what aspects of these changes we might carry over when we return to near normal working conditions.
"For those who join us, we would like to know what kind of innovation solutions you and your colleagues have developed, and share your stories and ideas to help and inspire others.”
Joining Chris on the panel will be a selection of veterinary professionals who will share their own experience of how they have had to adapt the way they work during the pandemic. Participants include Anita Patel, an RCVS-recognised Specialist in Veterinary Dermatology, who runs her own dermatology referral service, and Richard Artingstall, Clinical Director of Vale Referrals in Gloucestershire.
The event, which will feature short presentations followed by a reflective discussion, is free to attend and can be signed up to via its Eventbrite page at: www.eventbrite.co.uk/e/152857028487
More meetings are planned for later in the year:
If you have any questions about the sessions or would like to take part as a speaker, email the ViVet Manager, Sophie Rogers on s.rogers@rcvs.org.uk or info@vivet.org.uk
The updated guidance follows a public campaign known as ‘Tuk’s Law’, which was started after a healthy dog by that name was euthanased despite its microchip being dually registered with a rehoming centre as a 'rescue backup'.
In response, the RCVS and the BVA agreed that more should be done to prevent occasions where a dog might be needlessly put to sleep, but voiced concerns that a legislative approach could undermine a vet’s clinical judgement, unfairly involve veterinary surgeons in ownership disputes or potential criminality, and leave vets unfairly exposed to financial sanctions.
In consultation with Defra, the RCVS and BVA therefore jointly agreed to strengthen the Code of Professional Conduct as follows:
Chapter 8 (para 8.9)
There may be circumstances where a request is made by a client for the destruction of a dog, where in the clinical/professional judgement of the veterinary surgeon destruction of the dog is not necessary, for instance where there are no health or welfare reasons for the dog to be euthanised.
In these circumstances, before carrying out the request for euthanasia the veterinary surgeon should scan the dog for a microchip and check the relevant database if a microchip is found.
Chapter (paras 29.25 -29.27)
Clients may have a contract with the shelter from which they acquired the dog such that it can be returned to that shelter, and that it may be appropriate to discuss this with them prior to euthanasia. Alternatively, there may be another individual willing to take responsibility for the dog (who may be named on the microchip database), and this may also be discussed with the client.
The updated guidance supports existing best practice in terms of discussing alternatives to euthanasia with clients, and give vets flexibility where, in their professional judgment, scanning is not appropriate; this might be if scanning would itself cause a welfare problem, or where a vulnerable client might be involved.
The RCVS Standards Committee says it recognised the difficulties experienced by veterinary surgeons in dealing with the current microchip database system, but felt that introducing these provisions into the guidance was a more proportionate response than the alternative of legislation with substantial fines.
BVA Senior Vice President Dr Daniella Dos Santos MRCVS said: “One of the most important jobs as a vet is having those difficult conversations with clients about euthanasia where we talk through all the options that are in the animal’s best interests. But where the vet doesn’t consider that euthanasia is necessary, the new guidance clearly sets out the steps we need to take. We support this constructive approach that addresses the campaigners’ concerns without undermining veterinary judgement.”
Ms Burrows faced 11 charges against her.
The first alleged that in November 2017 she had allowed or caused her horse to be re-registered at the Cardiff equine practice where she worked under a different patient name, and had failed to consolidate and cross-reference this new record with the previous one.
The second charge alleged that between November 2017 and March 2018 she failed to make entries into the practice’s clinical records for her horse about its epistaxis and the investigations into the condition.
Charges 3 to 9 related to various telephone conversations and email exchanges Ms Burrows had with NFU Mutual in 2018 in which she failed to disclose the horse’s full clinical history and knowingly gave false statements to the effect that the horse’s condition of epistaxis had started more recently than it actually had. These charges also include asking an administrative colleague in the practice to, unknowingly, provide the insurance company with false information.
Charge 10 alleged that Ms Burrows asked a colleague to provide incorrect and/or dishonest information to the insurance company about the date of an endoscopy that had been performed on her horse in or around November or December 2017.
The final charge (Charge 11) alleged that, in regard to all previous charges, Ms Burrows had acted dishonestly.
At the outset of the hearing Ms Burrows admitted to Charges 2 to 9, as well as charge 11 in so far as it related to these charges.
However, she denied that she had allowed the creation of a new record for her horse under a different name for the purposes of concealing its clinical history or that she had attempted to induce a veterinary surgeon colleague to provide false information about the treatment of her horse.
Nevertheless, the Committee found all the charges proven.
Next the Committee considered whether the charges amounted to serious professional misconduct.
In doing so the Committee considered the pre-meditated nature of Ms Burrows’ conduct in setting up the second record for her horse with the intention of benefitting financially by providing false information. Likewise, the Committee considered that Ms Burrows had abused her professional position by asking her colleague who was a practice administrator to, unknowingly, provide false information to the insurance company on her behalf and in attempting to induce a veterinary surgeon colleague to lie on her behalf.
The Committee found her guilty of serious professional misconduct in respect of all 11 charges and stated that her conduct could be characterised as deplorable.
Cerys Jones, chairing the Committee and speaking on its behalf, said: “The Committee noted that, in the event, no actual harm had been occasioned to any animal or person. There had been an attempt at, but no actual, financial gain. The Committee had not been informed of any previous regulatory findings against Ms Burrows. In addition Ms Burrows had made some, limited, admissions to the College in her responses to it and has admitted a number of the Charges, including her dishonesty, before the Committee. Ms Burrows has apologised for that to which she admitted and in the Committee’s view has displayed a limited degree of insight.”
Having determined serious professional misconduct, the Committee then went on to consider the appropriate sanction for Ms Burrows. Ahead of the decision she made representations to the Committee in which she acknowledged that she had let the profession down, multiple breaches of the Code, and highlighted that her actions had prejudiced the delicate relationship between the public and the profession and had tarnished the reputation of the profession. She asked the Committee for the opportunity for a second chance, saying that she had started her own veterinary practice now and that honesty and integrity were now integral to her practice.
The Committee also heard several character witnesses as well as testimonials from both professional colleagues and clients attesting to her integrity and capabilities as a veterinary surgeon. Ms Burrows’ counsel also highlighted that at the time of the misconduct she was young and relatively new to veterinary practice and had been going through a difficult time, both professionally and personally.
Ultimately, however, the Committee decided that removal from the Register was the most appropriate and proportionate sanction.
Cerys Jones, speaking on behalf of the Committee, said: “In the view of the Committee, honesty in a veterinary surgeon is a fundamental professional issue, and that is the case regardless of age and experience. The public, other professionals and insurers all at times rely on the word of a professional veterinary surgeon to honestly attest to matters of importance. All need to be able to trust the veterinary surgeon. Any departure from a standard of honesty undermines public confidence in the profession.
“In the Committee’s determination, Ms Burrows had shown a repeated disregard for the principle of honesty on a number of occasions when dealing with the insurance claim in her telephone calls. Moreover, the Committee had found that Dr Burrows had caused or allowed the preparation of documentation concealing the full history of her horse and attempted to involve another professional in the matter.
“The Committee had found that Ms Burrows’ dishonesty had extended over approximately five months, and she had had several opportunities to resile from it. However, it took until [a colleague] raised the issue with Ms Burrows before she took steps to end the claim.
“The Committee determined that Ms Burrows had put her own interests ahead of those of the public and undermined the trust that underpins the relationship with insurers.”
She added: “In the Committee’s determination, the repeated dishonesty in the case in all the circumstances could not be met other than by directing that Ms Burrows’ registration be removed from the Register.”
Ms Burrows has 28 days from being informed of the outcome of the hearing to appeal the Committee’s decision.
Jack Fellows, Elanco swine sales leader, said: "With the potential zinc oxide restrictions coming into place next year, it’s crucial that vets work with their farmers to start trialling alternative PWD prevention strategies now, while the use of zinc is still permitted.
“Keeping PWD at bay going forward will require a multifaceted approach to piglet management. Gradually reducing the level of zinc oxide, while simultaneously incorporating alternative preventive techniques, will reduce the likelihood of problems arising during this transition.
“It’s far more convenient to have the vaccine in a 200 head dose, rather than the current pack size that offers 50 treatments. This will greatly cut down the time required to dilute and stabilise multiple individual packs, while helping to minimise any margin of error during administration."
Research has shown over 90% of farmers1 would head to their vet as the first port of call when it comes to advice on treating PWD.
“It’s crucial that vets are aware of all the preventive tools and options for managing the disease as over half of farmers surveyed2 also said they would treat PWD with antibiotics, which is obviously something we’re trying to steer away from as an industry, and why vaccines play such an important role going forwards.
“The Coliprotec vaccine is proven to prevent against these issues, delivering healthy pigs that reach a heavier market weight up to 7 days earlier3, while substantially reducing the in-nursery use of antibiotic treatments."
To mark the launch of the new 200 dose pack size, Elanco is offering veterinary practices the chance to buy five packs for the price of four, a total of 1000 doses, through their wholesaler.
For more information, contact Jack Fellows at jack_michael.fellows@elancoah.com or call 07771 798157.
Clomicalm contains Clomipramine hydrochloride, a broad-spectrum tricyclic antidepressant that inhibits the neuronal reuptake of serotonin and norepinephrine. A non-sedative, Clomicalm is used in combination with behavioural modification techniques to help separation anxiety.
Itrafungol is an oral solution containing Itraconazole for the treatment of ringworm in cats, administered orally directly into the mouth by means of a dosing syringe.
Both Clomicalm and Itrafungol are available to order from the veterinary wholesalers.
For more information, speak to your Virbac Territory Manager.
The study “Hypoadrenocorticism in dogs under UK primary veterinary care: frequency, clinical approaches and risk factors1”, identified dogs diagnosed with hypoadrenocorticism from the electronic patient records of practices participating in the UK VetCompass programme during 2016.
The study aimed to estimate the frequency of hypoadrenocorticism in dogs under primary veterinary care in the UK, describe the diagnosis and clinical management of hypoadrenocorticism and report the risk factors for the disease.
Cases were categorised as having a laboratory-confirmed or presumed diagnosis, based on the information available in the electronic patient records. Multivariable logistic regression was used to identify demographic risk factors.
A total of 177 hypoadrenocorticism cases were identified from 905,543 dogs in 2016; 72 laboratory-confirmed and 105 presumed. The one-year period prevalence for hypoadrenocorticism in all dogs was 0.06%.
The most commonly recorded clinical signs included:
Imogen Schofield, corresponding author for the paper, said: “By presenting epidemiological data on dogs with hypoadrenocorticism attending primary-care practice, this study provides representative and relatable information for vets working in primary-care practice in the UK. It should be borne in mind that diagnostic and clinical management data were reported for laboratory-confirmed cases only.
“Breed, age, neuter status and insurance status were all associated with a laboratory-confirmed diagnosis of hypoadrenocorticism. The standard poodle had 51.38 times the odds of hypoadrenocorticism compared with crossbreeds. The labradoodle (OR: 7.40) and West Highland white terrier (OR: 5.84) also had increased odds.
Nicola Di Girolamo, Editor of JSAP, said: “This is the largest study to date to provide benchmark data on hypoadrenocorticism in dogs under primary veterinary care in the UK. Given that the frequency of hypoadrenocorticism has rarely been reported, it is typically difficult to diagnose due to the non-specific clinical signs associated with the disease, and many previous studies have focussed on referral populations. This is a welcome publication adding to the evidence base of an important topic.”
The full article can be found in the May issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13285. It is open access and can be freely accessed by anyone.
The survey is the second stage of a three stage review recommended to RCVS Council by the College’s Standards Committee in 2019, after it looked at the implications of new technologies for both animal welfare and veterinary regulation.
The main areas under consideration include the provision of 24/7 emergency cover and the interpretation and application of an animal being under the care of a veterinary surgeon. The review also encompasses remote consulting.
In stage one of the review, the RCVS commissioned a research agency to conduct a series of focus group discussions with veterinary professionals working in a variety of roles and sectors. The information gleaned from the discussions was then used to develop the questions for this survey.
The survey will ask veterinary professionals to reflect on what, for them, should underpin good regulations and guidelines for practice.
It will then ask respondents how these principles should be applied in particular situations relating to 24/7 emergency cover and 'under care' before inviting their views on how they would like regulations on these two areas to deal with any tensions between different desirable regulatory aims.
The survey results will be used to help produce any changes to the RCVS Code of Professional Conduct and its supporting guidance concerning ‘under care’ and the provision of 24/7 emergency cover, which will then be put out for full public consultation later this year.
Chair of the RCVS Standards Committee, Dr Melissa Donald, said: “This review addresses fundamental questions about how we should continue to interpret ‘under care’ in a profession, and a society, that is largely unrecognisable to the one that first defined the term, and, at the same time, how we can continue to provide 24/7 emergency cover for those animals under our care.
“The original Vet Futures report also emphasised the impact that technological advances may have on the veterinary professions, so we must ensure we have in place a regulatory framework that gives consideration to these potential changes whilst ensuring animal health and welfare remain at its heart.
“These are challenging but hugely important questions on which we are hoping to receive as much feedback as possible. I do understand the huge pressures my vet and vet nurse colleagues continue to work under at the moment, so would like to thank them in advance for taking a little time out of their busy days to send us their views.”
The survey will open on Wednesday, 19th May 2021 for all UK-based veterinary surgeons and veterinary nurses.
All responses will be used and reported anonymously, so respondents will not be identified.
The survey will be open for four weeks, closing at 5pm on Wednesday, 16 June 2021.
It should take 15-20 minutes to complete, but can be returned to and completed in stages if preferred.
Further background information about the Under Care Review is available at www.rcvs.org.uk/undercare.
The 12-strong crew, aged between 18 and 60, left Marina San Miguel, Tenerife on 22nd March and rowed 2,875 nautical miles across the Atlantic Ocean, arriving in Falmouth Harbour, Antigua 42 days, 2 hours and 30 minutes later.
Each of the crew of the 12-metre boat, Roxy, rowed more than 1.5million strokes and burned over 5000 calories a day.
During the journey, the team had to battle with ocean storms and seasickness, not to mention extreme blisters and callouses. Simon lost almost 10kg.
Simon, who was a rowing novice before this, raised almost £15,000 for MacMillan Cancer Support. He said: "It’s without a doubt the hardest thing I’ve ever done. I can’t put into words how I’m feeling right now. The sense of achievement is a little overwhelming.
"The journey was everything I wanted it to be - tough both physically and mentally but hugely rewarding and one thing is for sure, I wouldn’t be standing here at the finish line if it hadn’t been for each and every one of the incredible crew. What a gorgeous group of people who will remain lifelong friends. After catching up with my family, the thing I was most looking forward to was a good meal!”.
The crew were welcomed to Antigua by a flotilla of smaller boats with many of the crew’s families onboard, before a reception at the Antigua Yacht Club.
The book contains 40 chapters of articles about clinical techniques, diagnostic pathways and management approaches published in Companion between 2016 and 2020.
Editor of Companion, Samantha Taylor said: “At Companion we strive to produce well-illustrated, practical articles to help vets and VNs in practice face the day-to-day challenges of a varied caseload. We hope this collection meets our aims by covering a variety of clinical problems from hypercalcaemia in cats to managing the snuffly rabbit, from Leishmaniasis to lymphoma and many more.
Ian Ramsey (BSAVA Senior Vice President) said: “This collection represents a unique body of well-illustrated work prepared by experts from all around the UK and beyond. I would like to thank them all on behalf of BSAVA members and readers of this book for taking the time and care to develop these resources for their colleagues around the world.”
Samantha added: “Whether kept on the shelf for when needed or thumbed through over a cup of tea, we hope that within the pages of this new volume you find a useful tip or technique that helps.”
The How to…collected articles from BSAVA Companion (2016–2020), 3rd edition has been published as a BSAVA member loyalty reward gift for those eligible veterinary members who renew their membership this year.
The book is also available to buy from the BSAVA website www.bsava.com/shop priced at £20.
The GDP offers one-to-one mentoring, alongside professional and clinical skills development in primary care practices across the UK.
Chloe Roberts, clinical and educational development manager at Linnaeus, said: “This fourth cohort of graduates is looking likely to be the biggest yet, which is testament to how successful the programme has become over recent years.
“We’ve received so many high-quality applications and look forward to welcoming many of them into our practices.
“There’s still time left for people to apply via our online portal, so we’d love to hear from any prospective candidates interested in roles in the Midlands and Yorkshire.”
Linnaeus delivers all clinical training in-house through its extensive network of specialists, referral clinicians, certificate holders and experienced primary care clinicians.
Graduates take part in 20 core educational days as part of their clinical and professional skills training, with access to an additional 10 CPD days to undertake training of their own choice over the course of the programme.
For more information about the Graduate Development Programme, visit https://graduates.linnaeusgroup.co.uk.
Photo: Bristol University graduate Abigail McCarthy, a vet at Blacks Vets in Dudley